In the BioHarmony Drug Report Database

"Preview" Icon

Dapiprazole

Dapiprazole, Abilify (dapiprazole) is a small molecule pharmaceutical. Dapiprazole was first approved as Dapiprazole on 1990-12-31. It is used to treat mydriasis in the USA. It has been approved in Europe to treat bipolar disorder and schizophrenia. The pharmaceutical is active against alpha-1D adrenergic receptor.

 

Trade Name

 

Abilify, Abilify Maintena
 

Common Name

 

dapiprazole
 

ChEMBL ID

 

CHEMBL1201216
 

Indication

 

bipolar disorder, mydriasis, schizophrenia
 

Drug Class

 

Antiulcer agents (benzimidazole derivatives)

Image (chem structure or protein)

Dapiprazole structure rendering